<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">abcimg</journal-id>
			<journal-title-group>
				<journal-title>ABC Imagem Cardiovascular</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Arq Bras Cardiol: Imagem cardiovasc.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="epub">2675-312X</issn>
			<publisher>
				<publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">abcimg.20240033i</article-id>
			<article-id pub-id-type="doi">10.36660/abcimg.20240033i</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Review Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>My Approach To Echocardiographic Evaluation in Arrhythmogenic Cardiomyopathy</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Moleta</surname>
						<given-names>Danilo Bora</given-names>
					</name>
					<role>Conception and design of the research</role>
					<role>writing of the manuscript</role>
					<role>critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Machado</surname>
						<given-names>Cassio Carvalho Soeiro</given-names>
					</name>
					<role>writing of the manuscript</role>
					<role>critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>França</surname>
						<given-names>Lucas Arraes de</given-names>
					</name>
					<role>critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Vieira</surname>
						<given-names>Marcelo Luiz Campos</given-names>
					</name>
					<role>critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="orgname">Hospital viValle</institution>
				<addr-line>
					<named-content content-type="city">São José dos Campos</named-content>
					<named-content content-type="state">SP</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Hospital viValle, São José dos Campos, SP – Brazil</institution>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="orgname">Hospital do Coração do Brasil</institution>
				<addr-line>
					<named-content content-type="city">Brasília</named-content>
					<named-content content-type="state">DF</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Hospital do Coração do Brasil, Brasília, DF – Brazil</institution>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="orgname">Hospital Israelita Albert Einstein</institution>
				<addr-line>
					<named-content content-type="city">São Paulo</named-content>
					<named-content content-type="state">SP</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Hospital Israelita Albert Einstein, São Paulo, SP – Brazil</institution>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="orgname">Universidade de São Paulo</institution>
				<institution content-type="orgdiv1">Instituto do Coraçã</institution>
				<addr-line>
					<named-content content-type="city">São Paulo</named-content>
					<named-content content-type="state">SP</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Universidade de São Paulo, Instituto do Coração, São Paulo, SP – Brazil</institution>
			</aff>
			<author-notes>
				<corresp id="c01">
					<label>Mailing Address</label>: Danilo Bora Moleta • Hospital viValle. Av. Linneu de Moura, 995. Postal Code: 12244-380. São José dos Campos, SP – Brazil E-mail: <email>dbmoleta@gmail.com</email>
				</corresp>
				<fn fn-type="edited-by">
					<p>Editor responsible for the review: Marcelo Tavares</p>
				</fn>
				<fn fn-type="conflict">
					<p>Potential Conflict of Interest</p>
					<p>No potential conflict of interest relevant to this article was reported.</p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>27</day>
				<month>08</month>
				<year>2024</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<month>08</month>
				<year>2024</year>
			</pub-date>
			<volume>37</volume>
			<issue>3</issue>
			<elocation-id>e20240033</elocation-id>
			<history>
				<date date-type="received">
					<day>3</day>
					<month>06</month>
					<year>2024</year>
				</date>
				<date date-type="rev-recd">
					<day>7</day>
					<month>06</month>
					<year>2024</year>
				</date>
				<date date-type="accepted">
					<day>8</day>
					<month>06</month>
					<year>2024</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Abstract</title>
				<p>Careful echocardiographic evaluation of the right ventricle, although challenging and sometimes neglected, is of utmost importance in the diagnosis of certain pathologies, such as arrhythmogenic cardiomyopathy (ACM) — a hereditary myocardial disease associated with the development of ventricular arrhythmias, heart failure, and sudden death. This article aims to review the diagnostic criteria proposed in the 2010 Task Force and the modifications suggested by the 2020 Padua criteria, as well as illustrate the potential use of advanced echocardiography techniques for earlier detection and prognostic definition.</p>
			</abstract>
			<kwd-group xml:lang="en">
				<kwd>Cardiomyopathies</kwd>
				<kwd>Arrhythmogenic Right Ventricular Dysplasia</kwd>
				<kwd>Ventricular Tachycardia</kwd>
				<kwd>Sudden Cardiac Death</kwd>
				<kwd>Right Ventricular Dysfunction</kwd>
			</kwd-group>
			<counts>
				<fig-count count="14"/>
				<table-count count="4"/>
				<equation-count count="0"/>
				<ref-count count="15"/>
			</counts>
		</article-meta>
	</front>
	<body>
				<p>
					<fig id="f01">
						<label>Central Illustration</label>
						<caption>
							<title>: My Approach To Echocardiographic Evaluation in Arrhythmogenic Cardiomyopathy</title>
							<p>Representation of measurements of RV diameters and their functional assessment on a two-dimensional echocardiography. Diameters of the proximal outflow tract evaluated in the parasternal window on the long axis (A) and on the short axis (B). Basal diameter in the apical 4-chamber window (C). Fractional variation in area, with assessment in diastole (D) and systole (E).</p>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf01.tif"/>
					</fig>
				</p>
		<sec sec-type="intro">
			<title>Introduction</title>
			<p>Arrhythmogenic cardiomyopathy (ACM) is one of the main causes of sudden death among young people and athletes.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> It is a genetically transmitted disease, characterized by the progressive replacement of the univentricular or biventricular myocardium by fibrofatty tissue that is predisposed to systolic dysfunction and potentially fatal ventricular arrhythmias.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Today we recognize that CMA actually corresponds to a group of diseases with different genotypes and phenotypic presentations.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
			<p>Initially, the pathology was described as a cardiac condition that involved ventricular arrhythmias, sudden death, and fibrofatty replacement of the right ventricular (RV) myocardium, and was then called arrhythmogenic RV dysplasia.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> With the advancement of the understanding of pathophysiology and the involved genetics, mainly with the recognition of the genetically determined defect in intercellular adherence by desmosomes, the disease was classified as cardiomyopathy.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> From carrying out magnetic resonance imaging (MRI) exams in patients with the diagnosis and evaluating the pathological anatomy of victims of sudden death, the involvement of the left ventricle (LV) was also recognized, and the term ACM was proposed.<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
			<p>The process of fibrofatty replacement begins in the epicardial or mesocardial layer, extending to transmural involvement, with wall thinning and the formation of aneurysms, typically located at the apex and in the inferior and infundibular walls of the RV (“classic triangle of dysplasia”).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> However, it was recognized that the apex of the RV is only impacted in the most severe forms of the disease and that another point of the triangle would be the lateral wall of the LV.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Generally, LV involvement provides more nonspecific findings on the echocardiogram, and there is an overlap with manifestations of other cardiomyopathies. The ventricular septum is normally spared in the disease.</p>
			<p>The current CMA classification includes the following phenotypic variants: right dominant, classic RV arrhythmogenic cardiomyopathy (RVAC), with minimal or no LV involvement; the biventricular variant, characterized by parallel involvement of the RV and LV; and LV arrhythmogenic cardiomyopathy (LVAC), with minimal or no RV involvement.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
			<p>In this article, our objective will be to review the diagnostic criteria proposed in the 2010 Task Force (TFC) and the modifications suggested by the 2020 Padua criteria, as well as illustrate the potential use of advanced echocardiography techniques for early detection and prognostic definition.<sup><xref ref-type="bibr" rid="B8">8</xref></sup></p>
			<sec>
				<title>Diagnosis</title>
				<p>The diagnosis is currently based on TFC 2010, involving a combination of data from different categories: imaging, electrocardiography, family history, genetics and histology. Imaging modalities include ventriculography, echocardiography, and MRI, with a qualitative assessment of RV contractility, in addition to few quantitative measurements of dimensions and systolic function (<xref ref-type="table" rid="t1">Table 1</xref>). The 2010 TFC does not involve structural findings related to the LV. The image category has a sensitivity of around 70% and a specificity of around 95%. The presence of segmental contractile alteration is mandatory in order to fulfill diagnostic criteria using imaging methods, with the degree of dilation and global dysfunction determining the definition of greater or lesser criteria. Isolated findings on imaging tests, without electrocardiographic changes, should be considered suspicious and do not enable a diagnosis of the disease. Patients with initial structural changes, which are difficult to detect using imaging methods, may present arrhythmias and sudden death. Therefore, it is important to refine diagnostic tools for early detection and prognostic stratification. Updated criteria, known as the “Padua criteria”, including involvement of the LV, have been proposed, but further validation is still necessary (<xref ref-type="table" rid="t2">Table 2</xref>).<sup><xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref></sup></p>
				<p>
					<table-wrap id="t1">
						<label>Table 1</label>
						<caption>
							<title>– Modified diagnostic criteria – 2010 Task Force</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup width="50%">
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" colspan="2">Imaging criteria for ACM</th>
								</tr>
								<tr>
									<th align="left" colspan="2">Overall or regional dysfunction and structural changes</th>
								</tr>
								<tr>
									<th align="left" style="font-weight:normal"> </th>
									<th align="left">Major</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>Echocardiogram</td>
									<td>RV with akinesia, dyskinesia or aneurysm AND one of the following parameters, measured at end-diastole: – RVOT in the long axis ≥ 32 mm – RVOT in the short axis ≥ 36 mm – FAC ≤ 33%</td>
								</tr>
								<tr>
									<td>Resonance</td>
									<td>RV with akinesia or dyskinesia or asynchronous contraction AND one of the following: – Indexed RV end-diastolic volume ≥ 110 ml/m<sup>2</sup> (man) or ≥ 100 ml/m<sup>2</sup> (woman) – RVEF ≤ 40%</td>
								</tr>
								<tr>
									<td>Ventriculography</td>
									<td>RV with akinesia, dyskinesia, or aneurysm</td>
								</tr>
								<tr>
									<td> </td>
									<td><bold>Minor</bold></td>
								</tr>
								<tr>
									<td>Echocardiogram</td>
									<td>RV with akinesia, dyskinesia, or aneurysm AND one of the following parameters, measured at end-diastole: – RVOT in the long axis ≥ 29 to &lt; 32 mm – RVOT in the short axis ≥ 32 to &lt; 36 mm – FAC &gt; 33% to ≤ 40%</td>
								</tr>
								<tr>
									<td>Resonance</td>
									<td>RV with akinesia or dyskinesia or asynchronous contraction AND one of the following: – Indexed RV end-diastolic volume ≥ 100 to &lt; 110 ml/m<sup>2</sup> (men) or ≥ 90 to &lt; 100 ml/m<sup>2</sup> (women) – RVEF &gt; 40% to ≤ 45%</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN1">
								<p>RV: right ventricle; RVOT: right ventricular outflow tract; FAC: fractional area variation; RVEF: right ventricular ejection fraction; ACM: arrhythmogenic cardiomyopathy.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>
					<table-wrap id="t2">
						<label>Table 2</label>
						<caption>
							<title>– International diagnostic criteria 2020 (Padua Criteria) – category of morphofunctional alterations</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup width="33%">
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th colspan="3">International criteria for AMC 2020 (Padua) – Morphofunctional Changes</th>
								</tr>
								<tr>
									<th align="left" style="font-weight:normal"> </th>
									<th align="left">RV</th>
									<th align="left">LV</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td> </td>
									<td><bold>Major</bold></td>
									<td><bold>Major</bold></td>
								</tr>
								<tr>
									<td>Echocardiogram, resonance, or ventriculography</td>
									<td>RV with akinesia, dyskinesia or aneurysm AND one of the following parameters: – Global RV dilation (according to references for each method for sex, age, and body surface); – Global systolic dysfunction (according to RVEF references for each method per sex and age)</td>
									<td>There are no criteria with sufficient specificity in this category.</td>
								</tr>
								<tr>
									<td> </td>
									<td><bold>Minor</bold></td>
									<td><bold>Minor</bold></td>
								</tr>
								<tr>
									<td>Echocardiogram, resonance, or ventriculography</td>
									<td>RV with akinesia, dyskinesia, or aneurysm, with no characterization of dilatation or global systolic dysfunction</td>
									<td>Global systolic dysfunction (reduction in LVEF or GLS), with or without dilation; Hypokinesia or akinesia of segments of the free wall, septum, or both</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN2">
								<p>Adapted from Corrado D et al. There is no major criterion for LV involvement in this imaging category, but there is a separate category of structural changes with a description of specific late enhancement patterns on MRIs. RV: right ventricle; LV: left ventricle; EF: ejection fraction; GLS: global longitudinal strain; AMC: arrhythmogenic cardiomyopathy; RVEF: right ventricular ejection fraction; LVEF: left ventricular ejection fraction.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Initial echocardiographic evaluation</title>
				<p>Echocardiography is the imaging modality initially used for screening, in conjunction with an MRI, and mainly for sequential evaluation, due to its low cost, availability, patient tolerance, and non-invasiveness. It is essential in the long-term follow-up of patients with an established diagnosis and the use of an implantable cardioverter defibrillator (ICD) of a model that is not compatible with the MRI. However, diagnosing AMC by echocardiography is challenging and requires experience. The identification of segmental contractile changes requires evaluation in multiple views, some of which are unusual in routine examinations. The peculiar anatomy of the right ventricle and the retrosternal position make it difficult to visualize its complex geometry.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
				<p>Although some of the parameters presented below are not part of the 2010 TFC, additional data demonstrating dysfunction may help identify cases that require surveillance or close follow-up.</p>
				<p>The 2010 TFC includes the following criteria, using two-dimensional echocardiography: akinesia, dyskinesia, or aneurysms, associated with increased diameters in the proximal RV outflow tract (RVOT) or reduced fractional variation in the RV area (FAC).<sup><xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref></sup></p>
				<p>The search for changes in RV segmental contractility should be carried out in parasternal long-axis views, parasternal views of the RV inlet, parasternal short-axis views from the basal level to the apex, apical 4-chamber views focused on the RV, and subcostal views, for a more complete assessment of the RV myocardial segments (<xref ref-type="fig" rid="f02">Figure 1</xref>). In patients with advanced disease, the detection of aneurysms is more frequent, and it is possible to detect intracavitary thrombi (<xref ref-type="fig" rid="f03">Figure 2</xref>).</p>
				<p>
					<fig id="f02">
						<label>Figure 1</label>
						<caption>
							<title>– View of the RV and its walls in the parasternal, apical 4-chamber windows focused on the RV and subcostal. RV: right ventricle; RVOT: right ventricular outflow tract; P: wall.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf02.tif"/>
					</fig>
				</p>
				<p>
					<fig id="f03">
						<label>Figure 2</label>
						<caption>
							<title>– Image compatible with intracavitary thrombus in an aneurysm at the apex of the RV in a patient with RVAC using an ICD. RV: right ventricle; RVAC: right ventricular arrhythmogenic cardiomyopathy; ICD: implantable cardioverter defibrillator</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf03.tif"/>
					</fig>
				</p>
				<p>The diameter of the RVOT can be measured in the parasternal long axis or short axis view (<xref ref-type="fig" rid="f01">Central Illustration – A and B</xref>). The short axis measurement is considered more robust and reproducible. In addition to the RVOT measurement recommendation from TFC 2010, it is also suggested to measure the basal, medium and longitudinal diameters in the apical 4-chamber view focused on the RV (<xref ref-type="fig" rid="f01">Central Illustration – C</xref>).<sup><xref ref-type="bibr" rid="B10">10</xref></sup> Since the latest guidelines for quantification of cardiac chambers published by the main echocardiography societies, the basal diameter has gained greater relevance and is currently the most commonly described in reports. However, when evaluating patients with suspected RVAC, for diagnostic definition, it is essential to also provide the diameter measurements obtained through the parasternal window in the report. Dilation of the RV, whether in the body or in the outflow tract, is associated with a worse prognosis, with a greater occurrence of serious arrhythmias.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
				<p>Regarding the functional assessment of the right ventricle, the most important measurement to be obtained for classification is the fractional variation of its area (FAC), which must be calculated from images obtained in the apical 4-chamber window focused on the RV, in diastole and in systole, with great attention paid to obtaining the complete edge of the cavity (including apex) and with the greatest possible definition of the free wall endocardium (<xref ref-type="fig" rid="f01">Central Illustration D and E</xref>). In addition to its diagnostic value, reduced FAC is associated with the occurrence of serious cardiovascular outcomes.<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
				<p>It is also recommended to evaluate other functional parameters on a conventional echocardiography, such as systolic excursion of the tricuspid annulus plane (TAPSE) and peak systolic velocity of the lateral tricuspid annulus (s’ wave). There are no specific cut-off values for basal diameter, TAPSE and s’ wave peak velocity in CMA, with the lower limits of normality to evaluate RV longitudinal function considered to be 17 mm and 9.5 cm/s, respectively. Both are usually reduced in RVAC with a definitive diagnosis, especially in advanced forms. The reduction in TAPSE is correlated with a worse prognosis in patients with an established diagnosis of RVAC.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> It should be remembered that these measurements are more representative of the basal longitudinal contraction of the RV. Thus, due to the characteristic segmental and focal involvement in RVAC, they can remain unchanged during the initial phases of the disease and even in more advanced forms that spare the base of the RV.</p>
				<p>In addition to the quantitative assessment of the RV, some findings from the subjective visual assessment are also relevant. The main ones are the presence of a hyperrefringent moderator band, an increase and disorganization of endocardial trabeculations at the apex of the RV and the appearance of saccules in the free wall (<xref ref-type="fig" rid="f04">Figure 3</xref>).</p>
				<p>
					<fig id="f04">
						<label>Figure 3</label>
						<caption>
							<title>– Hyperrefringence and increased trabeculation at the apex of the right ventricle in a patient with ACM.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf04.tif"/>
					</fig>
				</p>
				<p>As for the LV, using conventional two-dimensional echocardiography, the presence of reduced ejection fraction and segmental contractile changes should be monitored, especially in the basal lateral wall. However, any myocardial segment can be affected, without regard to coronary territories.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
			</sec>
			<sec>
				<title>Advanced echocardiographic evaluation</title>
				<p>The assessment of RV systolic function using speckle tracking echocardiography is gaining importance, especially in the early detection of dysfunction and the prognosis of various diseases. The possibility of evaluating longitudinal strain immediately after image acquisition on the echocardiography equipment itself and with automated software dedicated to the study of RV myocardial deformation contributes substantially to the potential use of this technique in daily practice.</p>
				<p>RV longitudinal strain is studied in the apical 4-chamber view focused on the RV. Currently, the role of the RV free wall strain (RVFWLS) is better defined, with its value calculated from the average of the systolic peak strain of the 3 segments of this wall. RV global longitudinal strain (RV GLS), obtained by averaging the systolic peak strain of the 6 segments evaluated in the apical 4-chamber view focused on the RV, is less used, especially in RVAC, in which there is no septal involvement (<xref ref-type="fig" rid="f05">Figure 4</xref>). There is a description of a reduction in longitudinal strain in the early stages of ACM, mainly in the subtricuspid region (basal segment of the free wall). There are no specific strain reference values for diagnosing ACM, and the same normality reference values defined for the assessment of the RV systolic function in the guidelines are suggested. There are authors who recommend a higher cutoff value for ACM screening, with an absolute value of 23% proposed for the RVFWLS. However, the absolute value for the most commonly used lower limit of normality is 20%.<sup><xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref></sup></p>
				<p>
					<fig id="f05">
						<label>Figure 4</label>
						<caption>
							<title>– Assessment of the longitudinal strain of the right ventricle (RV), in the apical 4-chamber view focused on the RV, showing the results of the reduced longitudinal strain of the RV free wall and GLS of the RV: -15.2% and - 12.8%, respectively.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf05.tif"/>
					</fig>
				</p>
				<p>In a cohort of patients being monitored at a reference Arrhythmology service, we obtained excellent sensitivity of the RVFWLS when identifying patients with RVAC, which was altered in 92% of them. In this same population, the major TF 2010 criteria were met in only 37% of patients using conventional echocardiography and 67% using MRI. In the same group of patients, absolute RVFWLS values below 14.35% were associated with a worse prognosis, with a greater occurrence of serious arrhythmic events.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
				<p>In addition to the deformation amplitude, the mechanical dispersion can be obtained from the systolic strain, calculated by the standard deviation of the time to peak of the strain, in the model of 3 or 6 segments of the RV, with cutoff values being &gt; 25 ms and &gt; 30 ms, respectively. Increased mechanical dispersion is associated with the presence of structural involvement typical of ACM and the occurrence of arrhythmias.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
				<p>The assessment of LV systolic function using speckle tracking is also relevant in ACM, especially considering the possibility of earlier diagnosis of LV involvement. The most commonly used parameter, due to practicality and availability, has been the LV global longitudinal strain (LV GLS), with the same normal values suggested in guidelines for quantifying cardiac chambers, with no specific cut-off values for ACM. The reduction in longitudinal deformation can be localized or diffuse, with no correlation to the coronary territory (<xref ref-type="fig" rid="f06">Figure 5</xref>).<sup><xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref></sup></p>
				<p>
					<fig id="f06">
						<label>Figure 5</label>
						<caption>
							<title>– Final result with polar map (bull’s eye) of the evaluation of GLS of the LV in a patient diagnosed with ACM and biventricular involvement.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf06.tif"/>
					</fig>
				</p>
				<p>LV involvement, with fibrofatty replacement of the myocardium, is also associated with the presence of low voltage on the electrocardiogram. In a cohort of 111 patients with ACM, the presence of a low-voltage electrocardiogram was an independent predictor of mortality due to heart failure and the need for transplantation.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
				<p>The study of LV mechanical dispersion, obtained at the end of the LV GLS assessment, has also been gaining ground, with a prognostic value being suggested in several situations, including ACM. In this condition, a dispersion above 45 ms indicates a worse prognosis.<sup><xref ref-type="bibr" rid="B15">15</xref></sup></p>
				<p>Three-dimensional echocardiography (3D ECHO) is also promising in the assessment of ACM, as it provides volumetric assessment of the RV and LV, with the possibility of calculating the three-dimensional ejection fraction (EF) for both ventricles, in a manner closer to an MRI of the heart (RMC) (<xref ref-type="fig" rid="f07">Figure 6</xref>). Three-dimensional imaging can facilitate the detection of segmental contractile changes due to the possibility of evaluating the three portions of the RV almost completely in a single acquisition. However, the role of 3D ECHO is greater in already established ACM, for the sequential assessment of biventricular systolic dysfunction. In the initial stages, there is normally no significant volumetric increase or reduction in ejection fraction, even when assessed by CMR.</p>
				<p>
					<fig id="f07">
						<label>Figure 6</label>
						<caption>
							<title>– Reconstrução tridimensional do VD de paciente com CMA. Em uma única aquisição é possível avaliar volumes, FE e contração segmentar das diferentes porções do VD.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf07.tif"/>
					</fig>
				</p>
				<p>Regarding the <italic>r</italic>ight ventricular ejection fraction (RVEF) by 3D ECHO, many cases have limited assessment due to an inadequate acoustic window for image acquisition or a very significant increase in the RV. Even so, its use for evaluating systolic function in diseases that affect the RV in general has already been recommended in the main guidelines, in places with availability and experience. RVEF &gt; 45% is considered normal. There are still no defined cutoff values for ACM.<sup><xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref></sup></p>
			</sec>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusion</title>
			<p>Echocardiography is extremely important in the initial and serial evaluation of patients with ACM. Imaging exams do not allow for a diagnosis to be made in isolation. The role of imaging exams is mainly to detect the changes necessary for diagnosis according to current criteria and provide prognostic information that can assist in clinical decisions in this complex scenario.</p>
			<p>The advancement of echocardiography and MRIs, combined with clinical, electrocardiographic, and genetic data in new algorithms, eventually associated with artificial intelligence to reduce interobserver variability, could contribute to earlier and more accurate diagnoses and produce better prognostic stratification with an impact on reducing mortality.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med. 2017;376(1):61-72. doi: 10.1056/NEJMra1509267.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Corrado</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Link</surname>
							<given-names>MS</given-names>
						</name>
						<name>
							<surname>Calkins</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<article-title>Arrhythmogenic Right Ventricular Cardiomyopathy</article-title>
					<source>N Engl J Med</source>
					<year>2017</year>
					<volume>376</volume>
					<issue>1</issue>
					<fpage>61</fpage>
					<lpage>72</lpage>
					<pub-id pub-id-type="doi">10.1056/NEJMra1509267</pub-id>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Corrado D, Marra MP, Zorzi A, Beffagna G, Cipriani A, Lazzari M, et al. Diagnosis of Arrhythmogenic Cardiomyopathy: The Padua Criteria. Int J Cardiol. 2020;319:106-14. doi: 10.1016/j.ijcard.2020.06.005.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Corrado</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Marra</surname>
							<given-names>MP</given-names>
						</name>
						<name>
							<surname>Zorzi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Beffagna</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Cipriani</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Lazzari</surname>
							<given-names>M</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Diagnosis of Arrhythmogenic Cardiomyopathy: The Padua Criteria</article-title>
					<source>Int J Cardiol</source>
					<year>2020</year>
					<volume>319</volume>
					<fpage>106</fpage>
					<lpage>114</lpage>
					<pub-id pub-id-type="doi">10.1016/j.ijcard.2020.06.005</pub-id>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Costa S, Cerrone M, Saguner AM, Brunckhorst C, Delmar M, Duru F. Arrhythmogenic Cardiomyopathy: An In-depth Look at Molecular Mechanisms and Clinical Correlates. Trends Cardiovasc Med. 2021;31(7):395-402. doi: 10.1016/j.tcm.2020.07.006.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Costa</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Cerrone</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Saguner</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Brunckhorst</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Delmar</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Duru</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Arrhythmogenic Cardiomyopathy: An In-depth Look at Molecular Mechanisms and Clinical Correlates</article-title>
					<source>Trends Cardiovasc Med</source>
					<year>2021</year>
					<volume>31</volume>
					<issue>7</issue>
					<fpage>395</fpage>
					<lpage>402</lpage>
					<pub-id pub-id-type="doi">10.1016/j.tcm.2020.07.006</pub-id>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right Ventricular Dysplasia: A Report of 24 Adult Cases. Circulation. 1982;65(2):384-98. doi: 10.1161/01.cir.65.2.384.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Marcus</surname>
							<given-names>FI</given-names>
						</name>
						<name>
							<surname>Fontaine</surname>
							<given-names>GH</given-names>
						</name>
						<name>
							<surname>Guiraudon</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Frank</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Laurenceau</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Malergue</surname>
							<given-names>C</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Right Ventricular Dysplasia: A Report of 24 Adult Cases</article-title>
					<source>Circulation</source>
					<year>1982</year>
					<volume>65</volume>
					<issue>2</issue>
					<fpage>384</fpage>
					<lpage>398</lpage>
					<pub-id pub-id-type="doi">10.1161/01.cir.65.2.384</pub-id>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-dominant Arrhythmogenic Cardiomyopathy: An Under-recognized Clinical Entity. J Am Coll Cardiol. 2008;52(25):2175-87. doi: 10.1016/j.jacc.2008.09.019.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sen-Chowdhry</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Syrris</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Prasad</surname>
							<given-names>SK</given-names>
						</name>
						<name>
							<surname>Hughes</surname>
							<given-names>SE</given-names>
						</name>
						<name>
							<surname>Merrifield</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Ward</surname>
							<given-names>D</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Left-dominant Arrhythmogenic Cardiomyopathy: An Under-recognized Clinical Entity</article-title>
					<source>J Am Coll Cardiol</source>
					<year>2008</year>
					<volume>52</volume>
					<issue>25</issue>
					<fpage>2175</fpage>
					<lpage>2187</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jacc.2008.09.019</pub-id>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Te Riele AS, James CA, Philips B, Rastegar N, Bhonsale A, Groeneweg JA, et al. Mutation-positive Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: The Triangle of Dysplasia Displaced. J Cardiovasc Electrophysiol. 2013;24(12):1311-20. doi: 10.1111/jce.12222.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Te Riele</surname>
							<given-names>AS</given-names>
						</name>
						<name>
							<surname>James</surname>
							<given-names>CA</given-names>
						</name>
						<name>
							<surname>Philips</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Rastegar</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Bhonsale</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Groeneweg</surname>
							<given-names>JA</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Mutation-positive Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: The Triangle of Dysplasia Displaced</article-title>
					<source>J Cardiovasc Electrophysiol</source>
					<year>2013</year>
					<volume>24</volume>
					<issue>12</issue>
					<fpage>1311</fpage>
					<lpage>1320</lpage>
					<pub-id pub-id-type="doi">10.1111/jce.12222</pub-id>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Corrado D, Basso C, Judge DP. Arrhythmogenic Cardiomyopathy. Circ Res. 2017;121(7):784-802. doi: 10.1161/CIRCRESAHA.117.309345.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Corrado</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Basso</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Judge</surname>
							<given-names>DP</given-names>
						</name>
					</person-group>
					<article-title>Arrhythmogenic Cardiomyopathy</article-title>
					<source>Circ Res</source>
					<year>2017</year>
					<volume>121</volume>
					<issue>7</issue>
					<fpage>784</fpage>
					<lpage>802</lpage>
					<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309345</pub-id>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806-14. doi: 10.1093/eurheartj/ehq025.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Marcus</surname>
							<given-names>FI</given-names>
						</name>
						<name>
							<surname>McKenna</surname>
							<given-names>WJ</given-names>
						</name>
						<name>
							<surname>Sherrill</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Basso</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Bauce</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Bluemke</surname>
							<given-names>DA</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria</article-title>
					<source>Eur Heart J</source>
					<year>2010</year>
					<volume>31</volume>
					<issue>7</issue>
					<fpage>806</fpage>
					<lpage>814</lpage>
					<pub-id pub-id-type="doi">10.1093/eurheartj/ehq025</pub-id>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O, et al. Comprehensive Multi-modality Imaging Approach in Arrhythmogenic Cardiomyopathy-an Expert Consensus Document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(3):237-53. doi: 10.1093/ehjci/jew229.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Haugaa</surname>
							<given-names>KH</given-names>
						</name>
						<name>
							<surname>Basso</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Badano</surname>
							<given-names>LP</given-names>
						</name>
						<name>
							<surname>Bucciarelli-Ducci</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Cardim</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Gaemperli</surname>
							<given-names>O</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Comprehensive Multi-modality Imaging Approach in Arrhythmogenic Cardiomyopathy-an Expert Consensus Document of the European Association of Cardiovascular Imaging</article-title>
					<source>Eur Heart J Cardiovasc Imaging</source>
					<year>2017</year>
					<volume>18</volume>
					<issue>3</issue>
					<fpage>237</fpage>
					<lpage>253</lpage>
					<pub-id pub-id-type="doi">10.1093/ehjci/jew229</pub-id>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39. doi: 10.1016/j.echo.2014.10.003.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lang</surname>
							<given-names>RM</given-names>
						</name>
						<name>
							<surname>Badano</surname>
							<given-names>LP</given-names>
						</name>
						<name>
							<surname>Mor-Avi</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Afilalo</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Armstrong</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ernande</surname>
							<given-names>L</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging</article-title>
					<source>J Am Soc Echocardiogr</source>
					<year>2015</year>
					<volume>28</volume>
					<issue>1</issue>
					<fpage>1</fpage>
					<lpage>39</lpage>
					<pub-id pub-id-type="doi">10.1016/j.echo.2014.10.003</pub-id>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Olivetti N, Sacilotto L, Moleta DB, França LA, Capeline LS, Wulkan F, et al. Enhancing Arrhythmogenic Right Ventricular Cardiomyopathy Detection and Risk Stratification: Insights from Advanced Echocardiographic Techniques. Diagnostics. 2024;14(2):150. doi: 10.3390/diagnostics14020150.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Olivetti</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Sacilotto</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Moleta</surname>
							<given-names>DB</given-names>
						</name>
						<name>
							<surname>França</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Capeline</surname>
							<given-names>LS</given-names>
						</name>
						<name>
							<surname>Wulkan</surname>
							<given-names>F</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Enhancing Arrhythmogenic Right Ventricular Cardiomyopathy Detection and Risk Stratification: Insights from Advanced Echocardiographic Techniques</article-title>
					<source>Diagnostics</source>
					<year>2024</year>
					<volume>14</volume>
					<issue>2</issue>
					<size units="pages">150</size>
					<pub-id pub-id-type="doi">10.3390/diagnostics14020150</pub-id>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Saguner AM, Vecchiati A, Baldinger SH, Rüeger S, Medeiros-Domingo A, Mueller-Burri AS, et al. Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Cardiovasc Imaging. 2014;7:230-9. doi: 10.1161/CIRCIMAGING.113.000210.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Saguner</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Vecchiati</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Baldinger</surname>
							<given-names>SH</given-names>
						</name>
						<name>
							<surname>Rüeger</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Medeiros-Domingo</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Mueller-Burri</surname>
							<given-names>AS</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia</article-title>
					<source>Circ Cardiovasc Imaging</source>
					<year>2014</year>
					<volume>7</volume>
					<fpage>230</fpage>
					<lpage>239</lpage>
					<pub-id pub-id-type="doi">10.1161/CIRCIMAGING.113.000210</pub-id>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Malik N, Mukherjee M, Wu KC, Zimmerman SL, Zhan J, Calkins H, et al. Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Imaging. 2022;15(2):e013725. doi: 10.1161/CIRCIMAGING.121.013725.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Malik</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Mukherjee</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>KC</given-names>
						</name>
						<name>
							<surname>Zimmerman</surname>
							<given-names>SL</given-names>
						</name>
						<name>
							<surname>Zhan</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Calkins</surname>
							<given-names>H</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy</article-title>
					<source>Circ Cardiovasc Imaging</source>
					<year>2022</year>
					<volume>15</volume>
					<issue>2</issue>
					<elocation-id>e013725</elocation-id>
					<pub-id pub-id-type="doi">10.1161/CIRCIMAGING.121.013725</pub-id>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Olivetti NQS, Sacilotto L, Wulkan F, Pessente GD, Carvalho MLP, Moleta D, et al. Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort. Circ Arrhythm Electrophysiol. 2023;16(2):e011391. doi: 10.1161/CIRCEP.122.011391.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Olivetti</surname>
							<given-names>NQS</given-names>
						</name>
						<name>
							<surname>Sacilotto</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Wulkan</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Pessente</surname>
							<given-names>GD</given-names>
						</name>
						<name>
							<surname>Carvalho</surname>
							<given-names>MLP</given-names>
						</name>
						<name>
							<surname>Moleta</surname>
							<given-names>D</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort</article-title>
					<source>Circ Arrhythm Electrophysiol</source>
					<year>2023</year>
					<volume>16</volume>
					<issue>2</issue>
					<elocation-id>e011391</elocation-id>
					<pub-id pub-id-type="doi">10.1161/CIRCEP.122.011391</pub-id>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Lie ØH, Rootwelt-Norberg C, Dejgaard LA, Leren IS, Stokke MK, Edvardsen T, et al. Prediction of Life-threatening Ventricular Arrhythmia in Patients with Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study. JACC Cardiovasc Imaging. 2018;11(10):1377-86. doi: 10.1016/j.jcmg.2018.05.017.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lie</surname>
							<given-names>ØH</given-names>
						</name>
						<name>
							<surname>Rootwelt-Norberg</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Dejgaard</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Leren</surname>
							<given-names>IS</given-names>
						</name>
						<name>
							<surname>Stokke</surname>
							<given-names>MK</given-names>
						</name>
						<name>
							<surname>Edvardsen</surname>
							<given-names>T</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Prediction of Life-threatening Ventricular Arrhythmia in Patients with Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study</article-title>
					<source>JACC Cardiovasc Imaging</source>
					<year>2018</year>
					<volume>11</volume>
					<issue>10</issue>
					<fpage>1377</fpage>
					<lpage>1386</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jcmg.2018.05.017</pub-id>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other">
				<label/>
				<p>Study Association</p>
				<p>This study is not associated with any thesis or dissertation work.</p>
			</fn>
			<fn fn-type="other">
				<label/>
				<p>Ethics Approval and Consent to Participate</p>
				<p>This article does not contain any studies with human participants or animals performed by any of the authors.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="financial-disclosure">
				<p>Sources of Funding</p>
				<p>There were no external funding sources for this study.</p>
			</fn>
		</fn-group>
	</back>
	<sub-article article-type="translation" id="TRpt" xml:lang="pt">
		<front-stub>
			<article-id pub-id-type="doi">10.36660/abcimg.20240033</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artigo de Revisão</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Como Eu Faço a Avaliação Ecocardiográfica na Cardiomiopatia Arritmogênica</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Moleta</surname>
						<given-names>Danilo Bora</given-names>
					</name>
					<role>Concepção e desenho da pesquisa</role>
					<role>redação do manuscrito</role>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff1002"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Machado</surname>
						<given-names>Cassio Carvalho Soeiro</given-names>
					</name>
					<role>redação do manuscrito</role>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff2002"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>França</surname>
						<given-names>Lucas Arraes de</given-names>
					</name>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff3002"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Vieira</surname>
						<given-names>Marcelo Luiz Campos</given-names>
					</name>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff3002"><sup>3</sup></xref>
					<xref ref-type="aff" rid="aff4002"><sup>4</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1002">
				<label>1</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Hospital viValle, São José dos Campos, SP – Brasil</institution>
			</aff>
			<aff id="aff2002">
				<label>2</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Hospital do Coração do Brasil, Brasília, DF – Brasil</institution>
			</aff>
			<aff id="aff3002">
				<label>3</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Hospital Israelita Albert Einstein, São Paulo, SP – Brasil</institution>
			</aff>
			<aff id="aff4002">
				<label>4</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade de São Paulo, Instituto do Coração, São Paulo, SP – Brasil</institution>
			</aff>
			<author-notes>
				<corresp id="c01002">
					<label>Correspondência</label>: Danilo Bora Moleta • Hospital viValle. Av. Linneu de Moura, 995. CEP: 12244-380. São José dos Campos, SP – Brasil E-mail: dbmoleta@gmail.com </corresp>
				<fn fn-type="edited-by">
					<p>Editor responsável pela revisão: Marcelo Tavares</p>
				</fn>
				<fn fn-type="conflict">
					<p>Potencial Conflito de Interesse</p>
					<p>Declaro não haver conflito de interesses pertinentes.</p>
				</fn>
			</author-notes>
				<abstract>
				<title>Resumo</title>
				<p>A avaliação ecocardiográfica criteriosa do ventrículo direito (VD), embora desafiadora e por vezes negligenciada, é de fundamental importância no diagnóstico de determinadas patologias, tais como a cardiomiopatia arritmogênica (CMA) – doença miocárdica hereditária associada ao desenvolvimento de arritmias ventriculares, insuficiência cardíaca e morte súbita. Este artigo tem o objetivo de revisar os critérios diagnósticos propostos na Task Force de 2010 e as modificações sugeridas pelos critérios de Pádua de 2020, além de ilustrar o uso potencial de técnicas avançadas de ecocardiografia para detecção mais precoce e definição prognóstica.</p>
			</abstract>
			<kwd-group xml:lang="pt">
				<kwd>Cardiomiopatias</kwd>
				<kwd>Displasia Arritmogênica Ventricular Direita</kwd>
				<kwd>Taquicardia Ventricular, Morte Súbita Cardíaca, Disfunção Ventricular Direita</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<p>
					<fig id="f01002">
						<label>Figura Central</label>
						<caption>
							<title>: Como Eu Faço a Avaliação Ecocardiográfica na Cardiomiopatia Arritmogênica</title>
							<p>Representação das medidas dos diâmetros do VD e de sua avaliação funcional ao ecocardiograma bidimensional. Diâmetros da via de saída proximal avaliados na janela paraesternal em eixo longo (A) e eixo curto (B). Diâmetro basal na janela apical 4 câmaras (C). Variação fracional da área, com avaliação na diástole (D) e na sístole (E).</p>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf01-pt.tif"/>
					</fig>
				</p>
			<sec sec-type="intro">
				<title>Introdução</title>
				<p>A cardiomiopatia arritmogênica (CMA) é uma das principais causas de morte súbita em jovens e atletas.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Trata-se de uma doença geneticamente transmitida, caracterizada pela substituição progressiva do miocárdio uni ou biventricular por tecido fibrogorduroso que predispõe à disfunção sistólica e a arritmias ventriculares potencialmente fatais.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Hoje reconhecemos que a CMA corresponde na realidade a um grupo de doenças com diferentes genótipos e apresentações fenotípicas.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
				<p>Inicialmente, a patologia foi descrita como uma condição cardíaca que cursava com arritmias ventriculares, morte súbita e substituição fibrogordurosa do miocárdio do ventrículo direito (VD), sendo então chamada displasia arritmogênica do VD.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Com o avanço do entendimento sobre a fisiopatologia e genética envolvidas, principalmente com o reconhecimento do defeito na adesão intercelular pelos desmossomos determinado geneticamente, a doença foi classificada como cardiomiopatia.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> A partir da realização de exames de ressonância magnética (RM) em pacientes com o diagnóstico e da avaliação pela anatomia patológica de vítimas de morte súbita, reconheceu-se o envolvimento também do ventrículo esquerdo (VE), sendo proposto o termo CMA.<sup><xref ref-type="bibr" rid="B5">5</xref></sup></p>
				<p>O processo de substituição fibrogordurosa tem início na camada epicárdica ou mesocárdica, com extensão para acometimento transmural, com afilamento de parede e formação de aneurismas, tipicamente localizados no ápice e nas paredes inferior e infundibular do VD (“triângulo da displasia” clássico).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Entretanto, foi reconhecido que o ápice do VD é apenas impactado nas formas mais graves da doença e que um outro ponto do triângulo seria a parede lateral do VE.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Geralmente o acometimento do VE proporciona achados mais inespecíficos no ecocardiograma e há sobreposição com manifestações de outras cardiomiopatias. Habitualmente o septo ventricular é poupado na doença.</p>
				<p>A classificação atual da CMA inclui as seguintes variantes fenotípicas: direito dominante, a cardiomiopatia arritmogênica do VD clássica (CAVD), com mínimo ou nenhum acometimento do VE; a variante biventricular, caracterizada por envolvimento paralelo de VD e VE; e a cardiomiopatia arritmogênica do VE (CAVE), com mínimo ou nenhum acometimento do VD.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
				<p>Neste artigo, nosso objetivo será revisar os critérios diagnósticos propostos na Task Force (TFC) de 2010 e as modificações sugeridas pelos critérios de Pádua de 2020, além de ilustrar o uso potencial de técnicas avançadas de ecocardiografia para detecção mais precoce e definição prognóstica.<sup><xref ref-type="bibr" rid="B8">8</xref></sup></p>
				<sec>
					<title>Diagnóstico</title>
					<p>O diagnóstico é atualmente baseado na TFC 2010, envolvendo combinação de dados de diferentes categorias: imagem, eletrocardiografia, história familiar, genética e histologia. As modalidades de imagem incluem ventriculografia, ecocardiografia e RM, com avaliação qualitativa de contratilidade do VD, além de poucas medidas quantitativas de dimensões e função sistólica (<xref ref-type="table" rid="t1002">Tabela 1</xref>). A TFC 2010 não envolve achados estruturais relacionados ao VE. A categoria de imagem tem sensibilidade ao redor de 70% e especificidade em torno de 95%. A presença de alteração contrátil segmentar é obrigatória para preencher critério diagnóstico pelos métodos de imagem, sendo o grau de dilatação e disfunção global determinantes para definir critério maior ou menor. Achados aos exames de imagem isolados, sem alterações eletrocardiográficas, devem ser considerados suspeitos e não permitem diagnosticar a doença. Pacientes com alterações estruturais iniciais, de difícil detecção aos métodos de imagem, podem apresentar arritmias e morte súbita. Assim, é importante refinar as ferramentas diagnósticas para detecção precoce e estratificação prognóstica. Foram propostos critérios atualizados, conhecidos como “critérios de Pádua”, incluindo acometimento do VE, porém ainda é necessária maior validação (<xref ref-type="table" rid="t2002">Tabela 2</xref>).<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup></p>
					<p>
						<table-wrap id="t1002">
							<label>Tabela 1</label>
							<caption>
								<title>– Critérios diagnósticos modificados – Task Force de 2010</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup width="50%">
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left" colspan="2">Critérios de imagem para CMA</th>
									</tr>
									<tr>
										<th align="left" colspan="2">Disfunção global ou regional e alterações estruturais</th>
									</tr>
									<tr>
										<th align="left" style="font-weight:normal"> </th>
										<th align="left">Maiores</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td>Ecocardiograma</td>
										<td>VD com acinesia, discinesia ou aneurisma E um dos parâmetros seguintes, medidos ao final da diástole: – VSVD no eixo longo ≥ 32 mm – VSVD no eixo curto ≥ 36 mm – FAC ≤ 33%</td>
									</tr>
									<tr>
										<td>Ressonância</td>
										<td>VD com acinesia ou discinesia ou contração assincrônica E um dos seguintes: – Volume diastólico final indexado do VD ≥ 110 ml/m<sup>2</sup> (homem) ou ≥ 100 ml/m<sup>2</sup> (mulher) – FEVD ≤ 40%</td>
									</tr>
									<tr>
										<td>Ventriculografia</td>
										<td>VD com acinesia, discinesia ou aneurisma</td>
									</tr>
									<tr>
										<td> </td>
										<td><bold>Menores</bold></td>
									</tr>
									<tr>
										<td>Ecocardiograma</td>
										<td>VD com acinesia, discinesia ou aneurisma E um dos parâmetros seguintes, medidos ao final da diástole: – VSVD no eixo longo ≥ 29 a &lt; 32 mm – VSVD no eixo curto ≥ 32 a &lt; 36 mm – FAC &gt; 33% a ≤ 40%</td>
									</tr>
									<tr>
										<td>Ressonância</td>
										<td>VD com acinesia ou discinesia ou contração assincrônica E um dos seguintes: – Volume diastólico final indexado do VD ≥ 100 a &lt; 110 ml/m<sup>2</sup> (homem) ou ≥ 90 a &lt; 100 ml/m<sup>2</sup> (mulher) – FEVD &gt; 40 a ≤ 45%</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN1002">
									<p>VD: ventrículo direito; VSVD: via de saída do ventrículo direito; FAC: variação fracional da área; FEVD: fração de ejeção do VD.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
					<p>
						<table-wrap id="t2002">
							<label>Tabela 2</label>
							<caption>
								<title>– Critérios diagnósticos internacionais 2020 (Critérios de Padua) – categoria alterações morfofuncionais</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup width="33%">
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th colspan="3">Critérios internacionais para CMA 2020 (Padua) – Alterações Morfofuncionais</th>
									</tr>
									<tr>
										<th align="left" style="font-weight:normal"> </th>
										<th align="left">VD</th>
										<th align="left">VE</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td> </td>
										<td><bold>Maiores</bold></td>
										<td><bold>Maiores</bold></td>
									</tr>
									<tr>
										<td>Ecocardiograma, ressonância ou ventriculografia</td>
										<td>VD com acinesia, discinesia ou aneurisma <bold>E</bold> um dos parâmetros seguintes: – Dilatação global de VD (conforme referências de cada método para sexo, idade e superfície corporal) – Disfunção sistólica global (conforme referências de FE VD de cada método para sexo e idade)</td>
										<td>Não há critérios com especificidade suficiente nessa categoria.</td>
									</tr>
									<tr>
										<td> </td>
										<td><bold>Menores</bold></td>
										<td><bold>Menores</bold></td>
									</tr>
									<tr>
										<td>Ecocardiograma, ressonância ou ventriculografia</td>
										<td>VD com acinesia, discinesia ou aneurisma, sem caracterização de dilatação ou disfunção sistólica global</td>
										<td>Disfunção sistólica global (redução de FE ou GLS VE), com ou sem dilatação; Hipocinesia ou acinesia de segmentos da parede livre, septo ou ambos</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN2002">
									<p>Adaptado de Corrado D et al. Não há critério maior para acometimento de VE nessa categoria de imagem, mas há categoria separada de alterações estruturais com descrição de padrões de realce tardio específicos na RM. VD: ventrículo direito; VE: ventrículo esquerdo; FE: fração de ejeção; GLS: strain longitudinal global; CMA: cardiomiopatia arritmogênica.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Avaliação ecocardiográfica inicial</title>
					<p>A ecocardiografia é a modalidade de imagem inicialmente usada para <italic>screening</italic>, em conjunto com a RM, e principalmente para avaliação sequencial, por seu baixo custo, disponibilidade, tolerância pelos pacientes e não invasividade. É fundamental no seguimento a longo prazo de pacientes com diagnóstico estabelecido e uso de cardiodesfibrilador implantável (CDI) de modelo não compatível com RM. No entanto, o diagnóstico da CMA pelo ecocardiograma é desafiador e exige experiência. A identificação de alterações contráteis segmentares requer avaliação em múltiplas incidências, algumas não usuais em exames rotineiros. A anatomia peculiar do VD e a posição retroesternal dificultam a visibilização de sua geometria complexa.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
					<p>Apesar de alguns dos parâmetros apresentados a seguir não fazerem parte da TFC 2010, dados adicionais que demonstrem disfunção podem auxiliar a identificar casos que requerem vigilância ou seguimento próximo.</p>
					<p>A TFC 2010 inclui como critérios por meio da ecocardiografia bidimensional: acinesia, discinesia ou aneurismas, associados a aumento de diâmetros na via de saída do VD (VSVD) proximal ou redução da variação fracional (FAC) da área do VD.<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup></p>
					<p>A busca por alterações da contratilidade segmentar do VD deve ser realizada nas incidências paraesternal em eixo longo, paraesternal da via de entrada do VD, paraesternal em eixo curto do nível basal ao ápice, apical 4 câmaras focada em VD e subcostal, para avaliação mais completa possível dos segmentos miocárdicos do VD (<xref ref-type="fig" rid="f02002">Figura 1</xref>). Em pacientes com doença avançada, a detecção de aneurismas é mais frequente, sendo possível a detecção de trombos intracavitários (<xref ref-type="fig" rid="f03002">Figura 2</xref>).</p>
					<p>
						<fig id="f02002">
							<label>Figura 1</label>
							<caption>
								<title>– Visualização do VD e suas paredes nas janelas paraesternal, apical 4 câmaras focado em VD e subcostal. VD: ventrículo direito; VSVD: via de saída do ventrículo direito; P: parede.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf02-pt.tif"/>
						</fig>
					</p>
					<p>
						<fig id="f03002">
							<label>Figura 2</label>
							<caption>
								<title>– Imagem compatível com trombo intracavitário em aneurisma no ápice do VD em paciente com CAVD em uso de CDI. VD: ventrículo direito; CAVD: cardiomiopatia arritmogênica do ventrículo direito; CDI: cardiodesfibrilador implantável.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf03-pt.tif"/>
						</fig>
					</p>
					<p>O diâmetro da VSVD pode ser medido na incidência paraesternal eixo longo ou eixo curto (<xref ref-type="fig" rid="f01002">Figura Central – A e B</xref>). A medida em eixo curto é considerada mais robusta e reprodutível. Além da recomendação de medida da VSVD da TFC 2010, sugere-se medir também os diâmetros basal, médio e longitudinal na incidência apical 4 câmaras focada em VD (<xref ref-type="fig" rid="f01002">Figura Central – C</xref>).<sup><xref ref-type="bibr" rid="B10">10</xref></sup> Desde as últimas diretrizes para quantificação de câmaras cardíacas publicadas pelas principais sociedades de ecocardiografia, o diâmetro basal ganhou maior relevância e é o mais descrito nos laudos atualmente. No entanto, ao avaliar pacientes com suspeita de CAVD, para definição diagnóstica, é fundamental fornecer no laudo também as medidas dos diâmetros obtidos por meio da janela paraesternal. Dilatação do VD, seja do corpo ou da via de saída, está associada a pior prognóstico, com maior ocorrência de arritmias graves.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
					<p>A medida mais importante a ser obtida para classificação funcional do VD é a sua FAC, que deve ser calculada a partir de imagens obtidas na janela apical 4 câmaras focada em VD, na diástole e na sístole, com muita atenção para obter a borda completa da cavidade (incluindo ápice) e com a maior definição possível do endocárdio da parede livre (<xref ref-type="fig" rid="f01002">Figura Central D e E</xref>). Além do valor diagnóstico, a redução da FAC está associada à ocorrência de desfechos cardiovasculares graves.<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
					<p>Recomenda-se, também, avaliar outros parâmetros funcionais ao ecocardiograma convencional, como excursão sistólica do plano do anel tricúspide (TAPSE) e pico da velocidade sistólica do ânulo tricuspídeo lateral (onda S). Não há valores de corte específicos para diâmetro basal, TAPSE e velocidade de pico da onda S na CMA, sendo considerados os limites inferiores de normalidade para avaliação da função longitudinal do VD de 17 mm e 9,5 cm/s, respectivamente. Ambos costumam estar reduzidos na CAVD com diagnóstico definitivo, principalmente nas formas avançadas. A redução do TAPSE apresenta correlação com pior prognóstico em pacientes com diagnóstico estabelecido de CAVD.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> Deve-se lembrar que essas medidas são mais representativas da contração longitudinal basal do VD. Dessa maneira, devido à característica de acometimento segmentar e focal na CAVD, podem permanecer inalteradas durante as fases iniciais da doença e mesmo nas formas mais avançadas que poupem a base do VD.</p>
					<p>Além da avaliação quantitativa do VD, alguns achados à avaliação visual subjetiva também são relevantes. Os principais são a presença de banda moderadora hiperrefringente, aumento e desorganização das trabeculações endocárdicas no ápice do VD e aspecto de saculações em parede livre (<xref ref-type="fig" rid="f04002">Figura 3</xref>).</p>
					<p>
						<fig id="f04002">
							<label>Figura 3</label>
							<caption>
								<title>– Hiperrefringência e aumento de trabeculação no ápice do VD em paciente com CMA.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf04-pt.tif"/>
						</fig>
					</p>
					<p>Por meio do ecocardiograma convencional bidimensional, deve-se rastrear a presença de redução da fração de ejeção (FE) e alterações contráteis segmentares no VE, principalmente na parede lateral basal. Porém pode ocorrer acometimento de qualquer segmento miocárdico, sem respeito a territórios coronarianos.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
				</sec>
				<sec>
					<title>Avaliação ecocardiográfica avançada</title>
					<p>A avaliação da função sistólica do VD por meio da ecocardiografia com <italic>speckle tracking</italic> vem ganhando importância, sobretudo na detecção precoce de disfunção e no prognóstico de diversas doenças. A possibilidade da avaliação do <italic>strain</italic> longitudinal imediatamente após aquisição de imagem no próprio equipamento de ecocardiografia e com softwares automatizados e dedicados ao estudo da deformação miocárdica ventricular direita contribui substancialmente para o potencial uso dessa técnica na prática diária.</p>
					<p>O <italic>strain</italic> longitudinal do VD é estudado na incidência apical 4 câmaras focada no VD. Atualmente está mais bem definido o papel do <italic>strain</italic> da parede livre do VD (RVFWLS – sigla do inglês para <italic>right ventricle free wall longitudinal strain</italic>), sendo seu valor calculado a partir da média do <italic>strain</italic> de pico sistólico dos 3 segmentos dessa parede. O <italic>strain longitudinal</italic> global do VD (RV GLS – sigla do inglês para <italic>right ventricle global longitudinal strain</italic>), obtido por meio da média do <italic>strain</italic> de pico sistólico dos 6 segmentos avaliados no corte apical de 4 câmaras focado no VD, é menos utilizado, principalmente na CAVD, em que não há acometimento septal (<xref ref-type="fig" rid="f05002">Figura 4</xref>). Há descrição de redução do <italic>strain</italic> longitudinal em fases iniciais da CMA, principalmente na região subtricúspide (segmento basal da parede livre). Não há valores de referência de <italic>strain</italic> específicos para diagnóstico da CMA, sendo sugeridos os mesmos valores de referência de normalidade definidos para avaliação da função sistólica do VD em diretrizes. Há autores que recomendam um valor de corte maior para rastreio da CMA, com valor absoluto de 23% proposto para o RVFWLS. Porém, o valor absoluto para o limite inferior de normalidade mais utilizado é de 20%.<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup></p>
					<p>
						<fig id="f05002">
							<label>Figura 4</label>
							<caption>
								<title>– Avaliação do strain longitudinal do VD, na visualização apical 4 câmaras focada em VD, com exibição dos resultados do strain longitudinal da parede livre do VD e strain longitudinal global do VD reduzidos: -15,2% e -12,8%, respectivamente.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf05-pt.tif"/>
						</fig>
					</p>
					<p>Em coorte de pacientes em acompanhamento em serviço de referência de arritmologia, obtivemos excelente sensibilidade do RVFWLS para identificação dos pacientes com CAVD, alterado em 92% deles. Nessa mesma população, os critérios maiores da TF 2010 foram preenchidos em apenas 37% dos pacientes pela ecocardiografia convencional e 67%, pela RM. No mesmo grupo de pacientes, valores absolutos de RVFWLS abaixo de 14,35% estiveram associados a pior prognóstico, com maior ocorrência de eventos arrítmicos graves.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
					<p>Além da amplitude de deformação, a partir do <italic>strain</italic> sistólico pode ser obtida a dispersão mecânica, calculada pelo desvio-padrão do tempo até o pico (<italic>time to peak</italic>) do <italic>strain</italic>, no modelo de 3 ou 6 segmentos do VD, com valores de corte sendo &gt; 25 ms e &gt; 30 ms, respectivamente. O aumento da dispersão mecânica está associado à presença de acometimento estrutural típico da CMA e à ocorrência de arritmias.<sup><xref ref-type="bibr" rid="B9">9</xref></sup></p>
					<p>A avaliação da função sistólica do VE pelo <italic>speckle tracking</italic> também é relevante na CMA, principalmente considerando a possibilidade de diagnóstico mais precoce do acometimento do VE. O parâmetro mais utilizado, pela praticidade e disponibilidade, tem sido o GLS VE, com os mesmos valores de normalidade sugeridos em diretrizes de quantificação de câmaras cardíacas, não havendo valores de corte específicos para a CMA. A redução de deformação longitudinal pode ser localizada ou difusa, sem guardar correlação com território coronariano (<xref ref-type="fig" rid="f06002">Figura 5</xref>).<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup></p>
					<p>
						<fig id="f06002">
							<label>Figura 5</label>
							<caption>
								<title>– Resultado final com mapa polar (bull’s eye) da avaliação de strain longitudinal global do VE em paciente com diagnóstico de CMA e acometimento biventricular.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf06-pt.tif"/>
						</fig>
					</p>
					<p>O acometimento do VE, com substituição fibrogordurosa do miocárdio, também está associado à presença de baixa voltagem ao eletrocardiograma. Em coorte com 111 pacientes com CMA, a presença de eletrocardiograma com baixa voltagem foi preditora independente de mortalidade por insuficiência cardíaca e necessidade de transplante.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
					<p>O estudo da dispersão mecânica do VE, obtida ao final da avaliação do GLS VE também vem ganhando espaço, com valor prognóstico sendo sugerido em diversas situações, entre elas a CMA. Nessa condição, uma dispersão acima de 45 ms indica pior prognóstico.<sup><xref ref-type="bibr" rid="B15">15</xref></sup></p>
					<p>A ecocardiografia tridimensional (ECO 3D) também é promissora na avaliação da CMA, ao proporcionar avaliação volumétrica do VD e do VE, com possibilidade de cálculo da FE tridimensional para ambos os ventrículos, de maneira mais próxima da RM de coração (RMC) (<xref ref-type="fig" rid="f07002">Figura 6</xref>). A imagem tridimensional pode facilitar a detecção de alterações contráteis segmentares, pela possibilidade de avaliar as 3 porções do VD de forma quase completa em uma única aquisição. No entanto, o papel do ECO 3D é maior na CMA já estabelecida, para avaliação sequencial de disfunção sistólica biventricular. Nas fases iniciais não costuma haver aumento volumétrico significativo ou redução de FE, mesmo quando avaliados pela RMC.</p>
					<p>
						<fig id="f07002">
							<label>Figura 6</label>
							<caption>
								<title>– Reconstrução tridimensional do VD de paciente com CMA. Em uma única aquisição é possível avaliar volumes, FE e contração segmentar das diferentes porções do VD.</title>
							</caption>
							<graphic xlink:href="2675-312X-abcimg-37-03-e20240033-gf07-pt.tif"/>
						</fig>
					</p>
					<p>Muitos casos de FE do VD pelo ECO 3D têm avaliação limitada por janela acústica inadequada para aquisição de imagem ou por aumento muito significativo do VD. Ainda assim, seu uso para avaliação de função sistólica em doenças que acometem VD de forma geral já vem sendo recomendado nas principais diretrizes, em locais com disponibilidade e experiência. Considera-se normal FE-VD &gt;45%. Ainda não há valores de corte definidos para CMA.<sup><xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup></p>
				</sec>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusões</title>
				<p>O ecocardiograma é de extrema importância na avaliação inicial e seriada de pacientes com CMA. Exames de imagem não permitem fechar diagnóstico isoladamente. O papel dos exames de imagem é principalmente detectar as alterações necessárias para o diagnóstico conforme os critérios atuais e fornecer informações prognósticas que podem auxiliar na decisão clínica nesse cenário complexo.</p>
				<p>O avanço da ecocardiografia e da RM aliado a dados clínicos, eletrocardiográficos e genéticos em novos algoritmos, eventualmente associados à inteligência artificial para redução de variabilidade interobservador, poderá contribuir para diagnósticos mais precoces e precisos e melhor estratificação prognóstica com impacto na redução de mortalidade.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="other">
					<p>Vinculação Acadêmica</p>
					<p>Não há vinculação deste estudo a programas de pós-graduação.</p>
				</fn>
				<fn fn-type="other">
					<p>Aprovação Ética e Consentimento Informado</p>
					<p>Este artigo não contém estudos com humanos ou animais realizados por nenhum dos autores.</p>
				</fn>
			</fn-group>
			<fn-group>
				<fn fn-type="financial-disclosure">
					<p>Fontes de Financiamento</p>
					<p>O presente estudo não teve fontes de financiamento externas.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
</article>